Michael Wang, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, briefly discusses the continued role of autologous and allogeneic stem cell transplantation (autoSCT; alloSCT) for patients with mantle cell lymphoma (MCL) in the era of CAR-T cell therapy. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.